Skin News and Research

RSS

Researcher from Hollings Cancer Center wins Melanoma Research Alliance grant

MUSC Hollings Cancer Center researcher Haizhen (Jen) Wang, Ph.D., recently was awarded a three-year $225,000 Young Investigator grant from the Melanoma Research Alliance.

29 May 2021

New biocompatible electrode prevents muscle loss in COVID-19 patients

A research group from Aarhus University has developed a special biocompatible electrode for electrical muscle stimulation that the group has integrated and 3D-printed onto medical support stockings.

29 May 2021

Methylene Blue could replace current sunscreen components to protect human skin and the environment

New research using a sunscreen based on Methylene Blue has proven effective in protecting from UV irradiation as well as being safe for coral reefs.

28 May 2021

Researchers map malaria parasites in unprecedented cellular detail

Researchers have mapped in fine detail the genetic changes malaria parasites go through as they prepare to infect people.

28 May 2021

Noble False Widow Spiders have public health implications, shows study

NUI Galway study confirms that the Noble False Widow spider does have public health implications. Research team have established a DNA database to allow clinicians dealing with cases to confirm the species identity using genetic analysis

27 May 2021

Vagus nerve stimulation may be a potential adjunct therapy for COVID-19

COVID-19 was initially described as lung inflammation, or pneumonia, in older adults. However, we now know that SARS-CoV-2 infections can cause a wide range of symptoms in people of all ages, ranging from no symptoms at all to systemic inflammation and even death.

27 May 2021

New porous biomaterial could help in bone repair

Scientists at Nanyang Technological University, Singapore (NTU Singapore) have developed a new biomaterial made entirely from discarded bullfrog skin and fish scales that could help in bone repair.

27 May 2021

Infrared thermal imaging camera can help monitor the progression of lymphatic filariasis

A paper published in the Journal of Clinical Medicine presents the results from a study which examined the use of an infrared thermal imaging camera as a novel non-invasive point-of-care tool for lymphatic filariasis lower-limb lymphoedema.

26 May 2021

‘Better than the hospital’: Pandemic boosts care for serious illnesses at home

Late last year, Janet Yetenekian was one of the thousands of people in Southern California whose case of covid-19 was serious enough to send her to the hospital.

26 May 2021

Long-term data from smartwatches can help estimate clinical blood test results

Smartwatches and other wearable devices may be used to sense illness, dehydration and even changes to the red blood cell count, according to biomedical engineers and genomics researchers at Duke University and the Stanford University School of Medicine.

26 May 2021

Study reveals how harmless skin microbes become deadly pathogens

The bacterium Staphylococcus epidermidisis primarily a harmless microbe found on the skin and in the noses of humans.

25 May 2021

Specific enzymes protect the human skin and body from microbes, viruses

The human body is constantly exposed to various environmental actors, from viruses to bacteria to fungi, but most of these microbial organisms provoke little or no response from our skin, which is charged with monitoring and protecting from external dangers.

22 May 2021

Researchers uncover differences in itch mechanisms

Chronic skin itching drives more people to the dermatologist than any other condition. In fact, the latest science literature finds that 7% of U.S. adults, and between 10 and 20% of people in developed countries, suffer from dermatitis, a common skin inflammatory condition that causes itching.

21 May 2021

FDA approves Rybrevant for treating subset of non-small cell lung cancer

Today, the U.S. Food and Drug Administration approved Rybrevant (amivantamab-vmjw) as the first treatment for adult patients with non-small cell lung cancer whose tumors have specific types of genetic mutations: epidermal growth factor receptor (EGFR) exon 20 insertion mutations.

21 May 2021

Trial results show upadacitinib to be the most effective treatment for atopic dermatitis

The findings of a clinical trial by Trinity College Dublin researchers of treatment for atopic dermatitis have been published today in The Lancet journal (Friday, 21st May, 2021).

21 May 2021

Risk factors for rare COVID-19 complications in children (MIS-C)

While the earlier waves of COVID-19 relatively spared children, some of the affected children have developed a systemic inflammatory condition, with occasionally fatal outcomes. Called multisystem inflammatory syndrome in children (MIS-C), its pathogenesis and risk factors are the subject of a new study on the medRxiv* preprint server.

21 May 2021

Dupilumab considerably reduced asthma exacerbations in young children, shows VOYAGE trial

Results from the VOYAGE study of dupilumab (Dupixent) showed that the monoclonal antibody significantly reduced exacerbations in children ages 6-11 with uncontrolled moderate-to-severe asthma, compared to placebo, according to research presented at the ATS 2021 International Conference. VOYAGE (NCT02948959) is a recently completed randomized, placebo-controlled double-blind multicenter phase 3 clinical trial, that took place in a number of countries.

20 May 2021

Phase 3 trial: New biologic therapy improves outcomes in adults, adolescents with severe asthma

Results from the NAVIGATOR study of tezepelumab showed that the new biologic therapy significantly reduced exacerbations requiring hospital stays and emergency department (ED) visits for adults and adolescents with severe, uncontrolled asthma, according to research presented at the ATS 2021 International Conference.

20 May 2021

Are COVID-19-related complications in children explained by abnormal immune responses?

A common theme in reports on COVID-19 around the world has been the large number of children who have not been infected or shown signs of disease. However, though the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes less acute infection in this age group, it is associated with a severe immune-mediated multisystemic illness called multisystem inflammatory syndrome in children (MIS-C).

20 May 2021

Protein intake is more important than protein source to gain muscle strength and mass

Protein intake is more important than protein source if the goal is to gain muscle strength and mass.

19 May 2021

Skin News and Research

Researcher from Hollings Cancer Center wins Melanoma Research Alliance grant

New biocompatible electrode prevents muscle loss in COVID-19 patients

Methylene Blue could replace current sunscreen components to protect human skin and the environment

Researchers map malaria parasites in unprecedented cellular detail

Noble False Widow Spiders have public health implications, shows study

Vagus nerve stimulation may be a potential adjunct therapy for COVID-19

New porous biomaterial could help in bone repair

Infrared thermal imaging camera can help monitor the progression of lymphatic filariasis

‘Better than the hospital’: Pandemic boosts care for serious illnesses at home

Long-term data from smartwatches can help estimate clinical blood test results

Study reveals how harmless skin microbes become deadly pathogens

Specific enzymes protect the human skin and body from microbes, viruses

Researchers uncover differences in itch mechanisms

FDA approves Rybrevant for treating subset of non-small cell lung cancer

Trial results show upadacitinib to be the most effective treatment for atopic dermatitis

Risk factors for rare COVID-19 complications in children (MIS-C)

Dupilumab considerably reduced asthma exacerbations in young children, shows VOYAGE trial

Phase 3 trial: New biologic therapy improves outcomes in adults, adolescents with severe asthma

Are COVID-19-related complications in children explained by abnormal immune responses?

Protein intake is more important than protein source to gain muscle strength and mass

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News